TY - JOUR AU - David C. Rees, PY - 2011/03/31 Y2 - 2024/03/29 TI - The rationale for using hydroxycarbamide in the treatment of sickle cell disease JF - Haematologica JA - haematol VL - 96 IS - 4 SE - Editorials DO - 10.3324/haematol.2011.041988 UR - https://haematologica.org/article/view/5923 SP - 488-491 AB - ER -